[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.150.215. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editor's Correspondence
October 11, 2010

Proton Pump Inhibitor Dose for Ulcer Bleeding: Is Less Really More?

Arch Intern Med. 2010;170(18):1697-1698. doi:10.1001/archinternmed.2010.357

Additional Information: Drs Leontiadis and Howden have collaborated on systematic reviews and meta-analyses on the role of PPIs in ulcer bleeding for the Cochrane Collaboration.

In their recent meta-analysis, Wang and colleagues concluded that high-dose intravenous proton pump inhibitor (PPI) regimens were not superior to non–high-dose regimens for patients with recent ulcer bleeding.1 However, we consider these conclusions to be premature, possibly flawed, and potentially misleading.

First Page Preview View Large
First page PDF preview
First page PDF preview
×